Attention Deficit Hyperactivity Disorder Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
- Healthcare IT
Attention deficit hyperactivity disorder is a disorder of brain, formerly known as attention deficit disorder. It is one of the most common mental disorders affecting children as well as adults. According to an estimation by the American Psychiatric Association, 2.5% of adults and 5% of children suffer from attention deficit hyperactivity disorder in the U.S. Among the children, the disorder is more common in boys than in girls. Attention deficit hyperactivity disorder is a condition where the patient has trouble in sitting still, focusing on tasks, and paying attention. The patient acts without thinking. This disorder can be diagnosed between the age of 6 and 12 years. The disorder is diagnosed by gathering information from teachers, parents, and others by performing a medical evaluation (including hearing and vision screening) and filling out checklists. No specific cause of the disorder is known.
Increase in the number of pre-term births of babies is a driving factor for the attention deficit hyperactivity disorder market. According to the University of Maryland Medical Center (UMMC), currently, 20% of the prematurely born babies develop this disorder. Increasing inclination of pregnant women toward toxins such as alcohol, cigarette, and drugs leads to children born with the attention deficit hyperactivity disorder. Complementary and alternative therapies such as special diets, vitamins, minerals, and herbs may restrain the attention deficit hyperactivity disorder market during the forecast period.
The attention deficit hyperactivity disorder market can be segmented on the basis of symptom type, treatment type, end-user, and region. Based on symptom type, the market can be classified into impulsivity (acting without thinking), hyperactivity (trouble in sitting still), and inattention (trouble in focusing). Based on treatment type, the market can be segmented into psychotherapy, medication, combination of treatments, and others. The psychotherapy segment can be sub-divided into family & marital therapy and behavioral therapy. The medication segment can further be classified into stimulants and non-stimulants. The medication segment is anticipated to hold a large market share during the forecast period, due to technological advancements and increasing R&D activities. Psychotherapy and combination of treatments segments are expected to expand at a moderate rate during the forecast period, owing to increasing awareness about attention deficit hyperactivity disorder among the people and technological advancements. Based on end user, the market can be segmented into pediatric clinics, psychological centers, hospitals and others.
Geographically, the global attention deficit hyperactivity disorder market can be divided into Asia Pacific, Latin America, Middle East & Africa, North America, and Europe. North America is expected to hold a leading market share from 2017 to 2025, owing to high usage of cigarettes, alcohol, and drugs during pregnancy in the region. According to the American Psychiatric Association, in the U.S., approximately 1 in 20 children is affected by attention deficit hyperactivity disorder. In terms of market share, Europe is projected to follow North America during the forecast period, due to high prevalence of attention deficit hyperactivity disorder in the region. For instance, the prevalence of attention deficit hyperactivity disorder is high in Ukraine, due to psychosocial dislocation and environmental adversity associated with the Chernobyl disaster. The market in Asia Pacific, Middle East & Africa, and Latin America is anticipated to expand at a significant rate during the forecast period, due to growing population of baby boomers and high rate of nutritional deficiencies and imbalances among children in developing countries in these regions.
Key players operating in the global attention deficit hyperactivity disorder market are Janssen Global Services, LLC, Cingulate Therapeutics, LLC, Shire, Eli Lilly and Company, Purdue Pharma L.P., GlaxoSmithKline plc, and Novartis AG.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017